176 related articles for article (PubMed ID: 29185269)
1. Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer.
Matsuo K; Shimada M; Saito T; Takehara K; Tokunaga H; Watanabe Y; Todo Y; Morishige KI; Mikami M; Sugiyama T
J Gynecol Oncol; 2018 Jan; 29(1):e11. PubMed ID: 29185269
[TBL] [Abstract][Full Text] [Related]
2. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T
Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298
[TBL] [Abstract][Full Text] [Related]
3. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
4. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
Matsuo K; Shimada M; Aoki Y; Sakamoto M; Takeshima N; Fujiwara H; Matsumoto T; Mikami M; Sugiyama T
Int J Cancer; 2017 Sep; 141(5):1042-1051. PubMed ID: 28524247
[TBL] [Abstract][Full Text] [Related]
6. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy.
Sakuragi N; Satoh C; Takeda N; Hareyama H; Takeda M; Yamamoto R; Fujimoto T; Oikawa M; Fujino T; Fujimoto S
Cancer; 1999 Apr; 85(7):1547-54. PubMed ID: 10193945
[TBL] [Abstract][Full Text] [Related]
7. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
Lee YJ; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Mar; 144(3):536-540. PubMed ID: 28108027
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
[TBL] [Abstract][Full Text] [Related]
10. Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer.
Matsuo K; Shimada M; Yamaguchi S; Kanao H; Nakanishi T; Saito T; Kamiura S; Iwata T; Mikami M; Sugiyama T
Int J Cancer; 2018 Mar; 142(5):1022-1032. PubMed ID: 28975603
[TBL] [Abstract][Full Text] [Related]
11. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.
Huang L; Zheng M; Liu JH; Xiong Y; Ding H; Tang L; Wang HY
Chin J Cancer; 2010 Apr; 29(4):431-5. PubMed ID: 20346221
[TBL] [Abstract][Full Text] [Related]
14. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment.
Del Carmen MG; Pareja R; Melamed A; Rodriguez J; Greer A; Clark RM; Rice LW
Gynecol Oncol; 2018 Sep; 150(3):406-411. PubMed ID: 30017539
[TBL] [Abstract][Full Text] [Related]
15. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between metastasis in the para-aortic lymph nodes of cervical cancer and pathological features].
Yu KX; Zhou XR; Wang YQ
Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1132-1138. PubMed ID: 36319460
[No Abstract] [Full Text] [Related]
17. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
18. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
19. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
20. Retrospective study of pelvic and para-aortic lymph nodes positivity in stage 1A to 2A cervical cancer patients.
John Lim BB; Yong CM
Med J Malaysia; 2021 Jul; 76(4):534-540. PubMed ID: 34305115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
